{
    "Trade/Device Name(s)": [
        "CINtec\u00ae Histology"
    ],
    "Submitter Information": "Ventana Medical Systems, Inc.",
    "510(k) Number": "K212176",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PRB"
    ],
    "Summary Letter Date": "July 9, 2021",
    "Summary Letter Received Date": "July 12, 2021",
    "Submission Date": "June 30, 2021",
    "Regulation Number(s)": [
        "21 CFR 864.1865"
    ],
    "Regulation Name(s)": [
        "Cervical Intraepithelial Neoplasia (CIN) Test System"
    ],
    "Analyte Class(es)": [
        "anatomic pathology",
        "immunology"
    ],
    "Analyte(s)": [
        "p16INK4a protein"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded (FFPE) cervical punch biopsy tissue"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VENTANA BenchMark ULTRA"
    ],
    "Method(s)/Technology(ies)": [
        "Immunohistochemistry (IHC)",
        "Mouse monoclonal antibody staining"
    ],
    "Methodologies": [
        "Qualitative immunohistochemistry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for CINtec Histology immunohistochemical test using mouse monoclonal anti-p16 antibody for detection of p16INK4a protein in FFPE cervical tissue biopsies",
    "Indications for Use Summary": "Qualitative immunohistochemistry test for p16INK4a protein in FFPE cervical punch biopsy tissues as an adjunct to H&E stained slide examination to improve consistency in diagnosing cervical intraepithelial neoplasia",
    "fda_folder": "Pathology"
}